Triumvira Immunologics Establishes Collaboration with Merck to Evaluate Cell Therapy
This media release was originally shared by Triumvira Immunologics on PR Newswire and BioSpace on January 5, 2023 AUSTIN, Texas and HAMILTON, ON and SOUTH SAN FRANCISCO, Calif., Jan. 5, 2023 /PRNewswire/ — Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics…